Biotech | September 21, 2021
Pfizer and BioNTech’s Covid-19 vaccine safe for children aged 5 to 11: study
In participants 5 to 11 years of age, the vaccine was safe, well-tolerated and showed robust neutralising antibody responses. Results in children under 5 years of age are expected as soon as later this year
_256_275.jpg)